North America Minimally Invasive Surgery Robot Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product and Services (Robotic Systems, Instruments and Accessories, and Services), Applicatio

The North America Minimally Invasive Surgery Robot Market is projected to grow significantly, reaching an estimated US$ 13,392.9 million by 2031, up from US$ 5,084.7 million in 2024. This growth represents a compound annual growth rate (CAGR) of 15.0% from 2025 to 2031, driven by several key factors.

Executive Summary

The market for minimally invasive surgery robots in North America is being propelled by the increasing adoption of automated surgical instruments, supportive government initiatives aimed at enhancing healthcare delivery, and a rising prevalence of chronic diseases. Additionally, the growing number of regulatory approvals for surgical robots is further contributing to market expansion in the region.

Market Segmentation Analysis

The North America Minimally Invasive Surgery Robot Market can be segmented based on product and services, application, and end use:

• By Product and Services: The market is divided into Robotic Systems, Instruments and Accessories, and Services. In 2024, Instruments and Accessories are expected to hold the largest market share.
• By Application: The market is categorized into General Surgery, Gynecological Surgery, Urological Surgery, Neurosurgery, Orthopedic Surgery, and Others. General Surgery is anticipated to dominate the market in 2024.
• By End Use: The market is segmented into Hospitals, Ambulatory Surgery Centers, and Others, with Hospitals expected to hold the largest share in 2024.

Market Outlook

The demand for precise and minimally invasive surgical procedures is on the rise across various specialties, including neurosurgery, ophthalmology, urology, cardiovascular, and reconstructive surgery. Microsurgery, which involves intricate procedures using specialized instruments and microscopes, is particularly prevalent in fields such as ophthalmology, neurosurgery, ENT, and vascular surgery.

Globally, there are approximately 22.6 million neurosurgical consultations each year, with around 13.8 million requiring surgical intervention. In the United States alone, the American Society of Plastic Surgeons reported 157,740 breast reconstruction procedures in 2023, a significant increase from previous years. Furthermore, vascular surgeons in the US perform over 100,000 surgeries annually, primarily addressing conditions like peripheral artery disease (PAD). Additionally, around 20 million cataract surgeries are conducted worldwide each year, with approximately 3.7 million occurring in the US.

The increasing volume of these procedures underscores the critical role of microsurgical techniques in modern healthcare, highlighting the growing need for advanced minimally invasive solutions.

Country Insights

The North America Minimally Invasive Surgery Robot Market is primarily segmented by country into the United States, Canada, and Mexico, with the United States holding the largest market share in 2024. The US is recognized as the largest market for minimally invasive surgery robots globally, driven by a high demand for advanced medical technologies that enhance patient care and a rising incidence of bone degenerative diseases.

Recent advancements in technology have led to significant regulatory approvals for new surgical systems. For instance, in March 2024, Intuitive Surgical received FDA clearance for its next-generation da Vinci 5 multiport robotic system. Similarly, Moon Surgical obtained FDA clearance in June 2024 for its innovative Maestro surgical system. These developments reflect the ongoing innovation in the field and the commitment to improving surgical outcomes.

Moreover, hospitals across the US are increasingly launching robotic surgery programs. For example, in June 2023, South Texas Health System Heart initiated a robotic surgery program aimed at enhancing patient outcomes and experiences. Such strategic initiatives by healthcare providers and market players are crucial in driving the growth of the minimally invasive surgery robot market in the US.

Competitive Landscape

Key players in the Minimally Invasive Surgery Robot Market include Medtronic Plc, Stryker Corp, Johnson & Johnson, Zimmer Biomet Holdings Inc, Smith & Nephew Plc, Intuitive Surgical Inc, Asensus Surgical Inc, CMR Surgical Ltd, Moon Surgical, and CUREXO, INC. These companies are actively pursuing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

In conclusion, the North America Minimally Invasive Surgery Robot Market is poised for substantial growth, driven by technological advancements, increasing surgical procedure volumes, and a strong focus on improving patient outcomes through minimally invasive techniques. Show more